BRIEF REPORT |
Correspondence to: Daniel S. Friend, Div. of Rheumatology and Immunology, Smith Building, Rm. 628, One Jimmy Fund Way, Boston, MA 02115.
![]() |
Summary |
---|
![]() ![]() ![]() ![]() |
---|
We have observed extensive mast cell degranulation in the reperfused hindlimb muscle of the mouse, accompanied by pathological changes within the muscle. As quantitated by the tissue:blood 125I permeability ratio, both the hindlimbs and lungs exhibited a significant increment in permeability during hindlimb reperfusion. In lungs of the same mice, mast cell-derived chymase mMCP-1 coats alveolar macrophages, an event noted by us in acid-induced direct lung injury. Mast cells in the lung contain mMCP-1, whereas those in the muscle do not. Neither extensive muscle injury nor an increased pulmonary permeability index occurs in the mast cell-deficient W/Wv mice. We conclude that the mast cell is a key mediator in both local ischemiareperfusion injury (IR) of muscle and consequent remote lung injury. (J Histochem Cytochem 49:10551056, 2001)
Key Words: ischemiareperfusion, hindlimb, lung, mast cell
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() |
---|
Post-ischemia hindlimb reperfusion initiates both local limb and remote organ injury. Experimental data have implicated mast cells in reperfusion injury of the lung (
The results (mean ± SEM) were analyzed by one-way ANOVA and Bonferroni correction for multiple comparisons. Percentage reduction in PI was calculated after subtraction of background values in sham (+/+) animals. Hindlimb IR injury markedly enhanced the skeletal muscle and lung permeability indices in the mast cell-sufficient (+/+) mice. The muscle PI was 1.602 ± 0.064 (n=4, p<0.05) compared to 0.0250 ± 0.019 in the sham mice. In the mast cell-deficient (W/Wv) mice there was a 52% reduction in muscle PI to 0.883 ± 0.047 (n=4, p<0.05). Remote lung injury was significantly elevated in the IR +/+ mice, PI 0.015 ± 0.003 (n=4, p<0.05) in comparison with the sham mice, PI 0.003 ± 0.001(n=4), and with W/Wv (-/-) mice subjected to IR, PI 0.005 ± 0.001 (n=4).
Histologically, mast cell degranulation along with neutrophil margination and extravasation from the capillaries, myofibril disruption, and myonecrosis were demonstrated in the biopsied muscle of the +/+ mice. In contrast, aside from the wavy fibers, muscle structure was generally preserved in the mast cell-deficient (W/Wv) animals (Fig 1). Although the PI for remote lung injury was 1000-fold less than for the directly involved hindlimb, the lungs also demonstrated extensive injury with interstitial edema and neutrophil sequestration in the mast cell-sufficient (+/+) group. The congenic W/Wv group did not demonstrate such morphology. Some mast cells in the (+/+) lungs stained for mMCP-1 and mMCP-2 by immunohistochemistry before and after the IR event. After the IR injury, the MMCP-1 IgG also coated clusters of alveolar macrophages (Fig 2). The muscle mast cells did not stain for mMCP-1 but were positive for mMCP-2 before and after IR.
|
Post-ischemia reperfusion of hindlimbs is known to lead to muscle and remote organ injury. Mast cell activation is followed by the elaboration of many mediators of three general categories: preformed, residing in the secretory granules, amines, proteases, proteoglycans; newly generated from released arachidonic acid (prostanoids and leukotrienes); and induced (cytokines and chemokines). This study demonstrates a definitive role for mast cells, either directly or indirectly, in initiating local muscle injury and in lung leukosequestration and edema after hindlimb ischemiareperfusion. The study also suggests that the mast cell protease mMCP-1 may act as a cell signaling factor for alveolar macrophages.
![]() |
Footnotes |
---|
Presented in part at the Joint Meeting of the Histochemical Society and the International Society for Analytical and Molecular Morphology, Santa Fe, NM, February 27, 2001.
Received for publication November 28, 2000; accepted February 16, 2001.
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() |
---|
Barr ML, Carey JN, Nishanian GP, Roberts RF, Sakamaki Y, Darbinian SH, Starnes VA (1998) Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury. J Thorac Cardiovasc Surg 115:631-636
Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL (1996) Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J Cell Biol 135:279-290[Abstract]
Goldman G, Welbourn R, Klausner JM, Kobzik L, Valeri CR, Shepro D, Hechtman H (1992) Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents. Surgery 112:578-586[Medline]